The article you requested is
Commentary: Randomized Controlled Trials of Olanzapine Treatment of Borderline Personality Disorder: Two Similar Studies With Different Results
J Clin Psychiatry 2011;72(10):1363-1365
Copyright 2011 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $40
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP print + online for $166 individual.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
The author presents a comparison of 2 large concurrently conducted, industry-sponsored, randomized, placebo-controlled pharmacotherapy trials using essentially the same protocols and outcome measures and differing primarily on fixed-dose versus flexible-dose olanzapine administration for treatment. Since the published reports of these 2 trials are 2+ years apart, with 1 included in the same issue as this commentary, it is important to bring together the results of these trials.